乳房切片市場規模、佔有率、成長分析、按產品、按適應症、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球乳房切片市場規模將為8.421億美元，預測期間（2024-2031年）複合年成長率為8.2%，從2023年的9.1115億美元成長到2031年的17.1163億美元。

由於乳癌發病率上升以及人們對早期檢測重要性的認知不斷增強，全球乳房切片市場正在顯著成長。推動這種擴張的關鍵因素包括對微創手術的日益偏好以及診斷影像和切片檢查技術的技術進步。市場上有多種切片檢查技術，包括粗針切片、輔助抽吸和細針抽吸，隨著影像導引切片檢查以提高準確性的趨勢不斷成長。自動化系統和手持工具等切片檢查設備的創新正在提高手術效率和患者舒適度。雖然北美因其高乳癌發病率和強大的醫療基礎設施而引領市場，但亞太和拉丁美洲的新興國家準備投資更好的醫療保健，並提高乳癌篩檢意識，預計將快速成長。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

乳房切片市場規模：依產品及複合年成長率（2024-2031）

• 市場概況
• 切片穿刺針
  • 粗針切片
  • 細針吸引針
• MRI導引切片檢查系統
• 超音波引導乳房切片系統
  • 2D乳房X光攝影超音波掃描系統
  • 3D B型乳房X光攝影超音波掃描系統
• 吸引輔助裝置
• 導管導引線
• 乳房切片標記物

乳房切片市場規模：按適應症和複合年成長率（2024-2031）

• 市場概況
• 複雜囊腫
• 固態物質
• 可疑固態物質
• 可疑的微鈣化

乳房切片市場規模：按最終用戶和複合年成長率（2024-2031）

• 市場概況
• 醫院
• 專科診所
• 癌症研究所

乳房切片市場規模：按地區和複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Hologic, Inc.（USA）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Argon Medical Devices（USA）
• Merit Medical Systems（USA）
• Menarini-Silicon Biosystems（Italy）
• Guardant Health, Inc.（USA）
• NeoGenomics（USA）
• Sysmex Inostics（Germany）
• Ethicon Endo-Surgery, Inc.（USA）
• CR Bard, Inc.（USA）
• Leica Biosystems Nussloch GmbH（Germany）
• Encapsule Medical Devices LLC（USA）
• Intact Medical Corporation（USA）
• Galini SRL（Italy）
• Cook Medical Incorporated（USA）
• Medtronic plc（Ireland）
• Devicor Medical Products, Inc.（USA）
• Carestream Health, Inc.（USA）
• Planmed Oy（Finland）

結論和建議

Global Breast Biopsy Market size was valued at USD 842.1 million in 2022 and is poised to grow from USD 911.15 million in 2023 to USD 1711.63 million by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The global breast biopsy market is experiencing significant growth, driven by rising breast cancer incidence and increased awareness of the importance of early detection. Key factors fueling this expansion include technological advancements in imaging and biopsy techniques, alongside a growing preference for minimally invasive procedures. The market features a variety of biopsy methods, including core needle, vacuum-assisted, and fine needle aspiration, with an increasing trend toward image-guided biopsies for enhanced accuracy. Innovations in biopsy devices, such as automated systems and handheld tools, are improving procedural efficiency and patient comfort. While North America leads the market due to high breast cancer prevalence and robust healthcare infrastructure, emerging economies in Asia-Pacific and Latin America are anticipated to grow rapidly, propelled by better healthcare investment and heightened awareness of breast cancer screening.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Breast Biopsy Market Segmental Analysis

Global Breast Biopsy Market is segmented by product, indication, end user and region. Based on product, the market is segmented into biopsy needles, MRI guide biopsy systems, ultrasound guided breast biopsy system, vacuum assisted devices, guide wire and breast biopsy markers. Based on indication, the market is segmented into complex cysts, solid mass, suspicious solid mass and suspicious micro calcifications. Based on end user, the market is segmented into hospitals, specialty clinics and cancer research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Breast Biopsy Market

A primary factor propelling the Global Breast Biopsy Market is the rising incidence of breast cancer across the globe. As one of the most frequently diagnosed cancers, breast cancer's prevalence has been on the upswing, amplifying the need for effective early detection and intervention strategies. This increasing cancer burden has heightened the focus on accurate diagnosis, leading to a surge in demand for breast biopsy procedures. Consequently, the necessity for reliable diagnostic methods to identify breast irregularities and facilitate prompt treatment has significantly spurred growth in the breast biopsy market, reflecting a critical aspect of contemporary healthcare advancements.

Restraints in the Global Breast Biopsy Market

One significant limitation affecting the Global Breast Biopsy Market is the risk of false-negative and false-positive results. Although breast biopsies are essential for accurate breast cancer diagnosis, there is a chance that these procedures might yield incorrect findings. False-negative results may arise when cancerous cells are not identified, resulting in delayed diagnoses or overlooked cases. Conversely, false-positive results can prompt unnecessary anxiety, leading to additional tests or invasive procedures for patients. These issues surrounding diagnostic accuracy can diminish trust in the reliability of breast biopsies, complicating the decision-making process for both healthcare providers and patients when determining appropriate treatment strategies.

Market Trends of the Global Breast Biopsy Market

A notable trend in the global breast biopsy market is the rising preference for image-guided biopsy techniques, including ultrasound, mammography, and MRI-guided biopsies. These advanced methods have gained traction due to their enhanced ability to precisely locate and sample suspicious breast lesions, thereby increasing diagnostic accuracy and minimizing invasiveness compared to traditional approaches. Real-time imaging allows for superior visualization, leading to higher diagnostic yields and reducing the likelihood of repeat procedures. This shift towards image-guided biopsies underscores the industry's commitment to improving the accuracy and efficiency of breast biopsy protocols, while also emphasizing patient comfort and minimizing procedural risks. As a result, this trend is poised to shape future developments in breast cancer diagnostics and intervention.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Breast Biopsy Market Size by Product & CAGR (2024-2031)

• Market Overview
• Biopsy Needles
  • Core Needles
  • Fine Aspiration Needles
• Mri Guide Biopsy Systems
• Ultrasound Guided Breast Biopsy System
  • 2D Mammographic Ultrasonic Scanning Systems
  • 3D B-Mode Mammographic Ultrasonic Scanning Systems
• Vacuum Assisted Devices
• Guide Wire
• Breast Biopsy Markers

Global Breast Biopsy Market Size by Indication & CAGR (2024-2031)

• Market Overview
• Complex Cysts
• Solid Mass
• Suspicious Solid Mass
• Suspicious Micro Calcifications

Global Breast Biopsy Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Specialty Clinics
• Cancer Research Institutes

Global Breast Biopsy Market Size & CAGR (2024-2031)

• North America (Product, Indication, End User)
  • USA
  • Canada
• Europe (Product, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Argon Medical Devices (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini-Silicon Biosystems (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Inostics (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon Endo-Surgery, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C. R. Bard, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems Nussloch GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Encapsule Medical Devices LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intact Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galini SRL (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Devicor Medical Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations